|
MedPal AI PLC on Tuesday said its wholly owned subsidiary MedPal Ltd, achieved a ‘record month’ in March, as it dispensed 41,600 prescriptions. The London-based digital health and AI company said the figure represents the highest monthly volume since operations began, up 28% on a monthly basis. Shares in the company surged 32% to 3.13 pence on Tuesday afternoon in London. MedPal AI said dispensing volumes have risen from zero to over 41,600 since October, reflecting rapid scaling of its automated pharmacy platform. The company noted that total items dispensed is now around 200,000, with its pharmacy operations generating in excess of £5 million in annualised turnover based on March figures. It added that gross margins for March were over 34%. Looking ahead, MedPal AI said it remains ‘highly confident’ in the company’s growth trajectory, as well as in the ‘significant’ market opportunity. ‘Dispatching over 41,000 items in March, our highest ever monthly total, is a landmark moment. In just five months, we have scaled from zero to an annualised pharmacy revenue run rate exceeding £5 million, and we have done this while delivering a gross margin of over 34% in March. This extraordinary rate of growth demonstrates the power of our vertically integrated, AI-driven model,’ said Chief Executive Jason Drummond. ‘Our technology-led cost structure means that as dispensing volumes grow, fixed costs are spread over a larger revenue base, driving further margin improvement. The traditional pharmacy model is being disrupted, and MedPal is leading that disruption. We look forward to updating the market on continued progress.’ Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
